Last Updated on: 11th May 2020, 05:23 pm
For a wide range of neurological conditions such as neurodegenerative diseases, brain injuries, visual impairments, motor neuron diseases, muscular dystrophies and hearing loss, Beike recommends treatment using umbilical cord blood stem cells (UCBSC). Our umbilical cord blood stem cells consist of several subsets of stem cells including Hematopoietic Stem Cells (HSC), Endothelial Progenitor Cells (EPC), Mesenchymal Stem Cells (MSC) and more, that allow differentiation into all blood cell lineages including immune cells from the innate and adaptive immune system as well as neural/nerve cells, muscle fibers, retinal ganglion cells, hepatic cells, chondrocytes (cartilage) and osteocytes (bone).
Moreover, this combination of stem cells is able to modulate the immune system (reduce inflammation or increase immune response depending on needs), release cytokines and growth factors, such as glia derived neurotrophic factor (GDNF), brain derived neurotrophic factor (BDNF), nerve growth factors (NGF), neurotrophin 3 (NT-3), neurotrophin 4/5 (NT 4/5), and stimulate patient’s own stem cells as well which further promotes regeneration. At this stage of stem cell research, it is believed that most of the benefits patients report have come from the cell growth factors and cytokines that are released by the stem cells after their administration.
